Nuvaxovid Offered as Alternative to mRNA Shots
For a virus (SARS-CoV-2) that many scientists and public health officials have maintained originated in a bat and accidently crossed over into humans, leading to the COVID-19 pandemic, it is odd that there does not appear to be much concern about producing vaccines that use genetic material from animals. You would think that this would […]
CDC Finds Glyphosate in Urine of Majority of Children in U.S.
A recent analysis by the U.S. Centers for Disease Control and Prevention (CDC) revealed that urine samples of approximately 87 percent of 650 children living in the United States had detectable levels of the weed killer pesticide glyphosate.1 What is Glyphosate? Glyphosate is the most widely used herbicide in the U.S. in the agricultural industry […]
Polio Case in New York Caused by “Vaccine-Derived” Poliovirus
Opinion | The first reported case of polio in the United States since 2013 was confirmed in New York last week. According to New York health officials, a young adult in Rockland County contracted type 2 “vaccine-derived” poliovirus (VDPV2), which may have been transmitted by someone who received the Sabin live attenuated oral polio vaccine (OPV). […]
VAERS Data Reveal Serious Adverse Event Reports in Babies After mRNA COVID Shots
On June 15, 2022, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the U.S. Food and Drug Administration (FDA) advised the FDA to grant an Emergency Use Authorization (EUA) for Moderna/NIAID and Pfizer/BioNTech’s mRNA COVID-19 biologics be given to infants and children under age five and as young as six months old. With […]
Research Confirms Menstrual Cycle Bleeding Changes After COVID Shot
Last week, University of Illinois researchers published a study funded by the National Institutes of Health (NIH) in the journal Science Advances on menstrual cycle bleeding changes after COVID shots. The study featured a web-based survey of almost 40,000 individuals and found 42 percent of those who were menstruating reported unexpected heavy bleeding after receiving […]
FDA Grants EUA for Novavax’s COVID Vaccine
Opinion | On July 13, 2022, the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) to Novavax to distribute its experimental two-dose NVX-CoV2373 (also known as “Nuvaxovid” and “Covovax”) COVID-19 vaccine for use by adults. The decision was expected, given the favorable recommendation by the FDA’s Vaccines and Related Biological Products Advisory […]